Pediatrics

👶 Neonatal Sepsis - Part 2

Diagnosis and Treatment

Common Pediatric Diseases and Disorders

A 2-day-old term infant presents with lethargy, poor feeding, and temperature instability. The clock starts ticking—delays in antibiotic administration significantly increase mortality. In this second part of our comprehensive guide to neonatal sepsis, we explore the diagnostic approach, treatment strategies, and prevention measures that can save lives and reduce long-term morbidity.

🔬 Diagnostic Approach

🔬 High Suspicion, Rapid Evaluation

The diagnosis of neonatal sepsis requires a high index of suspicion and systematic evaluation, as clinical signs are non-specific and laboratory tests have limitations.

When to Suspect Sepsis

  • Clinical Suspicion:
    • Any neonate "not acting right"
    • Temperature instability (especially hypothermia)
    • Respiratory distress, apnea
    • Feeding difficulties
    • Lethargy or irritability
    • Poor perfusion, hypotension
  • Risk Factor Assessment:
    • Maternal risk factors for EOS
    • Prematurity, low birth weight
    • NICU hospitalization with devices

Initial Evaluation

  • Complete Sepsis Evaluation:
    • Blood culture (gold standard)
    • Complete blood count (CBC) with differential
    • C-reactive protein (CRP)
    • Lumbar puncture if stable
    • Chest X-ray if respiratory symptoms
  • Additional Tests as Indicated:
    • Urine culture (LOS)
    • Surface cultures
    • Viral PCR if suspected
    • Blood gas, lactate
    • Coagulation studies if DIC suspected
Step 1: Clinical Assessment — Vital signs, perfusion, respiratory status, neurological status
Step 2: Risk Stratification — Maternal risk factors, neonatal risk factors, clinical presentation
Step 3: Laboratory Evaluation — Blood culture, CBC with differential, CRP, consider LP
Step 4: Imaging — Chest X-ray if respiratory symptoms, other imaging as indicated
Step 5: Initiate Empiric Therapy — Do not delay antibiotics while awaiting test results
Time to antibiotics: Delays in antibiotic administration significantly increase mortality. The first dose should be given within 1 hour of recognition of possible sepsis.

🧪 Laboratory Evaluation

🧪 Interpreting Diagnostic Tests

Laboratory evaluation in neonatal sepsis has limitations—no single test is both highly sensitive and specific. Results must be interpreted in clinical context.

Blood Culture

  • Gold Standard for Diagnosis:
    • Specificity: 100% (if not contaminated)
    • Sensitivity: 60-90% (depends on volume)
  • Optimal Technique:
    • Aseptic technique essential
    • Adequate blood volume: 1-2 mL (term), 0.5-1 mL (preterm)
    • Two bottles if possible (aerobic + anaerobic)
    • Time to positivity: Usually 12-48 hours
  • Limitations:
    • Low sensitivity with low-volume draws
    • Prior antibiotics may cause false negatives
    • Time delay to results

Complete Blood Count (CBC)

  • White Blood Cell Count (WBC):
    • Leukocytosis: >30,000/mm³ (sensitivity 30-50%)
    • Leukopenia: <5,000/mm³ (more specific for severe sepsis)
    • Normal range varies with gestational and postnatal age
  • Neutrophil Indices:
    • Absolute neutrophil count (ANC): <1,000 or >7,500
    • Immature:Total (I:T) ratio: >0.2 (most specific)
    • Band count: >1,500/mm³
  • Platelet Count:
    • Thrombocytopenia: <150,000/mm³
    • Often late finding, indicates DIC

Acute Phase Reactants

  • C-Reactive Protein (CRP):
    • Sensitivity: 60-90%
    • Specificity: 70-90%
    • Rises 6-12 hours after infection onset
    • Serial measurements more useful than single value
    • Normalizes with effective treatment
  • Procalcitonin (PCT):
    • Sensitivity: 85-95%
    • Specificity: 70-90%
    • Rises earlier than CRP (2-4 hours)
    • Less affected by perinatal factors
    • Useful for monitoring response to therapy

Cerebrospinal Fluid (CSF) Analysis

  • Indications for LP:
    • Positive blood culture
    • Clinical signs of meningitis
    • Uncertain diagnosis
    • Persistent symptoms despite antibiotics
    • Consider deferring if unstable
  • Normal CSF Values (Term):
    • WBC: <20 cells/mm³ (usually lymphocytes)
    • Protein: <120 mg/dL
    • Glucose: >50% of blood glucose
  • CSF Culture: Gold standard for meningitis diagnosis

📊 Interpretation of Laboratory Tests

Test Normal Range Concerning for Sepsis Comments
WBC count 9,000-30,000/mm³ <5,000 or >30,000 Leukopenia more ominous
I:T ratio <0.2 >0.2 Most specific hematologic test
Platelets 150,000-450,000 <150,000 Late finding, indicates DIC
CRP <1 mg/dL >1 mg/dL Serial measurements most useful
Procalcitonin <0.5 ng/mL >2 ng/mL Rises earlier than CRP
Serial monitoring: A single normal CBC or CRP does not rule out sepsis. Serial measurements over 24-48 hours are more reliable for both diagnosis and monitoring response to treatment.

💊 Treatment Strategies

💊 Empiric Antibiotic Therapy

Empiric antibiotic selection is based on the most likely pathogens, local resistance patterns, and whether the infection is early or late-onset.

Early-Onset Sepsis (EOS) Empiric Therapy

  • Standard Regimen:
    • Ampicillin + Gentamicin
    • Covers: GBS, E. coli, Listeria, other streptococci
  • Dosing:
    • Ampicillin: 50-100 mg/kg IV q8-12h
    • Gentamicin: 4-5 mg/kg IV q24-48h (dosing varies by gestational/postnatal age)
  • Considerations:
    • Add acyclovir if HSV suspected
    • Consider cefotaxime instead of gentamicin if meningitis suspected
    • Adjust based on local resistance patterns

Late-Onset Sepsis (LOS) Empiric Therapy

  • Standard Regimen:
    • Vancomycin + Aminoglycoside (gentamicin)
    • Or Vancomycin + Third-generation cephalosporin (cefotaxime)
    • Covers: CONS, S. aureus (including MRSA), gram-negatives
  • Dosing:
    • Vancomycin: 10-15 mg/kg IV q8-48h (based on gestational age, weight, renal function)
    • Cefotaxime: 50 mg/kg IV q8-12h
  • Special Considerations:
    • Add antifungal if risk factors for Candida
    • Consider broader gram-negative coverage if multidrug-resistant organisms suspected
    • Tailor based on local NICU antibiogram

Duration of Therapy

  • Uncomplicated Bacteremia: 7-10 days
  • Meningitis: 14-21 days (longer for some organisms)
  • Osteomyelitis: 4-6 weeks
  • Endocarditis: 4-6 weeks
  • Fungal Infections: Several weeks to months
  • Rule-out Sepsis (culture negative): 48-72 hours if asymptomatic and lab markers normalizing

Targeted Therapy Based on Organism

  • Group B Streptococcus: Penicillin G or ampicillin
  • E. coli: Cefotaxime or meropenem (if ESBL)
  • Coagulase-negative Staphylococci: Vancomycin
  • Staphylococcus aureus: Vancomycin (MRSA) or nafcillin (MSSA)
  • Pseudomonas aeruginosa: Antipseudomonal beta-lactam + aminoglycoside
  • Candida species: Amphotericin B or fluconazole
Antibiotic stewardship: While prompt initiation is critical, unnecessary prolonged antibiotic courses contribute to antimicrobial resistance, fungal infections, and NEC. Discontinue empiric antibiotics at 48-72 hours if cultures negative and clinical condition improved.
Step 1: Rapid Assessment — Clinical status, risk factors, likely source
Step 2: Empiric Antibiotics — Choose based on EOS vs LOS, administer within 1 hour
Step 3: Diagnostic Evaluation — Blood culture, CBC, CRP, consider LP
Step 4: Supportive Care — Respiratory, cardiovascular, metabolic support
Step 5: De-escalate/Target — Adjust antibiotics based on culture results and clinical course

🏥 Supportive Care and Management

🏥 Beyond Antibiotics

Comprehensive management of neonatal sepsis requires meticulous supportive care to address the multi-system consequences of infection and septic shock.

Respiratory Support

  • Oxygen Therapy: Maintain SpO₂ 90-95%
  • Non-invasive Ventilation: CPAP, high-flow nasal cannula
  • Mechanical Ventilation: For respiratory failure, apnea, or shock
  • Surfactant: Consider if pneumonia/ARDS with surfactant deficiency
  • Monitoring: Continuous pulse oximetry, blood gases

Cardiovascular Support

  • Fluid Resuscitation: 10-20 mL/kg normal saline (cautious in preterm)
  • Inotropic Support: Dopamine, dobutamine, epinephrine for shock
  • Monitoring: Blood pressure, perfusion, urine output
  • Volume Status: Careful balance - both under- and over-resuscitation harmful
  • Targets: Mean arterial pressure > gestational age, adequate perfusion

Metabolic and Hematologic Support

  • Glucose Management: Maintain normoglycemia (avoid both hypo- and hyperglycemia)
  • Electrolyte Balance: Monitor and correct sodium, potassium, calcium
  • Acid-Base Balance: Correct metabolic acidosis
  • Nutrition: Minimal enteral nutrition if stable, TPN if NPO
  • Hematologic: Transfusions for anemia, thrombocytopenia; consider IVIG in selected cases

Monitoring and Complications

  • Continuous Monitoring: Heart rate, respiratory rate, SpO₂, blood pressure
  • Laboratory Monitoring: CBC, CRP, cultures, electrolytes, blood gas
  • Complication Surveillance:
    • Meningitis (repeat LP if clinical concern)
    • Septic emboli, abscesses
    • Endocarditis (echocardiogram if persistent bacteremia)
    • DIC, thrombocytopenia
    • Acute kidney injury

🚨 Management of Septic Shock

  • First Hour (Golden Hour):
    • Airway, Breathing, Circulation assessment
    • Fluid bolus: 10-20 mL/kg (may repeat once)
    • Empiric antibiotics within 1 hour
    • Inotropes if fluid-resistant shock
    • Consider hydrocortisone if catecholamine-resistant shock
  • Ongoing Management:
    • Continuous hemodynamic monitoring
    • Mechanical ventilation if respiratory failure
    • Targeted temperature management
    • Metabolic support
    • Multidisciplinary team approach

🛡️ Prevention Strategies

🛡️ Reducing the Burden of Neonatal Sepsis

Prevention remains the most effective strategy for reducing neonatal sepsis morbidity and mortality, involving both maternal and neonatal interventions.

Maternal Prevention Strategies

  • Group B Streptococcus (GBS) Prophylaxis:
    • Universal screening at 35-37 weeks
    • Intrapartum antibiotic prophylaxis (IAP) for:
      • GBS positive mothers
      • Unknown GBS status with risk factors
      • Previous infant with invasive GBS disease
      • GBS bacteriuria during pregnancy
    • IAP reduces early-onset GBS by 80-90%
  • Other Maternal Interventions:
    • Appropriate management of chorioamnionitis
    • Treatment of maternal infections
    • Antenatal corticosteroids for preterm delivery
    • Prevention of preterm birth

Neonatal Prevention Strategies

  • Hand Hygiene: Single most effective measure
  • Central Line Bundle:
    • Hand hygiene
    • Maximal barrier precautions during insertion
    • Chlorhexidine skin antisepsis
    • Optimal site selection
    • Daily review of line necessity
  • Ventilator Bundle: To prevent VAP
  • Breastfeeding: Reduces infections
  • Minimize Device Use: Remove lines, tubes when no longer needed
  • Antibiotic Stewardship: Appropriate use and duration

NICU-Specific Prevention

  • Staff Education and Training:
    • Aseptic technique for procedures
    • Infection control practices
    • Early recognition of sepsis
  • Environmental Measures:
    • Adequate staffing
    • Appropriate patient spacing
    • Proper cleaning and disinfection
    • Water quality monitoring
  • Surveillance:
    • Infection rate monitoring
    • Outbreak detection
    • Antibiotic resistance patterns

Novel Prevention Strategies

  • Immunoprophylaxis:
    • Maternal GBS vaccination (in development)
    • RSV prophylaxis
  • Probiotics: Some evidence for reduction of NEC and late-onset sepsis in preterm infants
  • Chlorhexidine Wipes: For skin cleansing in low-resource settings
  • Antiseptic Umbilical Cord Care: In settings with high neonatal mortality
  • Kangaroo Mother Care: Reduces infections in preterm infants
GBS vaccine development: Maternal immunization against GBS is a promising strategy that could prevent both early- and late-onset GBS disease, potentially eliminating the need for intrapartum antibiotic prophylaxis.

⚠️ Complications and Outcomes

⚠️ Short and Long-Term Consequences

Neonatal sepsis can have both immediate complications and long-term sequelae, particularly in survivors of meningitis or severe septic shock.

Acute Complications

  • Septic Shock: 10-20% of cases
  • Meningitis: 10-30% of bacteremic cases
  • Disseminated Intravascular Coagulation (DIC): 5-10%
  • Acute Respiratory Distress Syndrome (ARDS): 5-15%
  • Acute Kidney Injury: 10-20%
  • Septic Emboli/Abscesses: 2-5%
  • Endocarditis, Osteomyelitis: 1-2%

Long-Term Sequelae

  • Neurodevelopmental Impairment:
    • Meningitis survivors: 20-50%
    • Cerebral palsy, cognitive impairment
    • Hearing loss (10-30% after meningitis)
    • Vision impairment, seizures
  • Chronic Lung Disease: Particularly in preterm survivors
  • Growth Failure: Often multifactorial
  • Renal Impairment: After acute kidney injury
  • Recurrent Infections: Immune dysregulation
Meningitis outcomes: Despite appropriate antibiotic therapy, neonatal meningitis carries significant mortality (10-15%) and high rates of neurodevelopmental sequelae in survivors (20-50%).

📈 Prognostic Factors

  • Poor Prognosis Indicators:
    • Extreme prematurity
    • Gram-negative or fungal etiology
    • Meningitis
    • Septic shock
    • Multi-organ failure
    • Persistent thrombocytopenia
    • Delayed antibiotic administration
  • Better Prognosis:
    • Term infant
    • Gram-positive bacteremia (except GBS)
    • Early appropriate antibiotic therapy
    • Rapid clinical improvement
    • No meningitis or end-organ damage

🔑 High-Yield Neonatal Sepsis Summary - Part 2

Aspect Key Points Clinical Applications
Diagnosis High suspicion, blood culture gold standard, I:T ratio most specific hematologic test Do not delay antibiotics for diagnostic tests; serial CRP useful for monitoring
Empiric Therapy EOS: ampicillin + gentamicin; LOS: vancomycin + gram-negative coverage Administer within 1 hour of recognition; tailor based on culture results
Supportive Care Respiratory, cardiovascular, metabolic support; fluid resuscitation cautious in preterm Multi-system approach; monitor for complications
Prevention GBS prophylaxis, hand hygiene, central line bundles, antibiotic stewardship Most effective strategy; reduces morbidity and mortality
Complications Meningitis, septic shock, long-term neurodevelopmental impairment Early recognition and treatment improves outcomes

🎯 Key Takeaways - Part 2

  • Time to antibiotic administration is critical—aim for within 1 hour of recognition
  • Blood culture remains the gold standard, but no single test is perfect—clinical judgment essential
  • Empiric antibiotic choice depends on early vs late-onset sepsis and local resistance patterns
  • Comprehensive supportive care is as important as antibiotics in severe sepsis
  • Prevention strategies, particularly GBS prophylaxis and infection control bundles, have significantly reduced neonatal sepsis incidence
  • Meningitis carries the highest risk of long-term neurodevelopmental sequelae
  • Antibiotic stewardship is crucial to prevent resistance and complications
  • Multidisciplinary team approach improves outcomes in severe sepsis and septic shock

🌟 The Lifesaving Difference

Neonatal sepsis represents one of the most challenging and time-critical emergencies in pediatrics. The difference between a good outcome and tragedy often comes down to early recognition, prompt antibiotic administration, and meticulous supportive care. Understanding the epidemiology, risk factors, clinical presentation, diagnostic approach, and management strategies provides the foundation for saving lives and reducing long-term morbidity.

As we continue to advance in prevention through maternal immunization, infection control bundles, and antibiotic stewardship, the burden of neonatal sepsis continues to decrease. However, vigilance remains essential—the subtle signs of sepsis in a newborn demand our utmost attention and rapid response.

Clinical Wisdom: "In neonatal sepsis, time is brain, time is organs, time is life. When in doubt, evaluate, culture, and treat." The cost of overtreatment is far less than the cost of missing sepsis.